Candel Therapeutics Inc. (CADL)

Market is closed

Sector: Biological Products, (No Disgnostic Substances)

Hedge Fund Popularity

Display

Display Share Price

Hedge Fund Holdings

Filing Period:

Last updated on February 14, 2024, 4:21 pm based on SEC 13F filings Last update: February 14, 2024, 4:21 pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Citadel Investment Group Ken Griffin	16,852	$24,772	-48%	0%
2.	Renaissance Technologies Jim Simons	18,675	$27,000		0%

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Martell	$1.92	23,950	Director	152,000	2022-12-09	Filing
Martell	$1.68	3,050	Director	128,050	2022-12-08	Filing
Barone	$1.61	1,238	Officer	2,738	2022-12-08	Filing
Papa	$1.94	35,018	Director	38,032	2022-12-09	Filing
Papa	$1.70	3,014	Director	3,014	2022-12-08	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Northpond Ventures, Llc	1,935,215	$2,844,766	13.53%
2.	Sands Capital Ventures, Llc	811,737	$1,193,253	0.33%
3.	Vanguard Group Inc	425,749	$625,851	0%
4.	Fmr Llc	298,384	$438,624	0%
5.	Geode Capital Management, Llc	139,253	$204,737	0%